ROCKVILLE, Md., March 3, 2015 /PRNewswire/ -- Synthetic
Biologics, Inc. (NYSE MKT: SYN), a developer of pathogen-specific
therapies for serious infections and diseases, with a focus on
protecting the microbiome, announced today that Jeffrey Riley, Chief Executive Officer, is
scheduled to present at the 27th Annual ROTH Conference being held
on March 8-11, 2015 at the
Ritz-Carlton, Laguna Niguel in
Dana Point, CA. Mr. Riley is
scheduled to present on Tuesday, March 10,
2015 at 1:00 p.m. (Pacific
Time).
A live webcast of Synthetic Biologics' presentation can be
accessed by logging onto the web at
http://wsw.com/webcast/roth29/syn. After the presentation, a replay
will be archived and accessible for 60 days at the same
website.
Mr. Riley, as well as Synthetic Biologics' Senior Vice
President, Clinical & Regulatory Affairs, Joe Sliman, MD, MPH, will be available to
participate in one-on-one meetings with investors who are
registered to attend the conference. In order to register, please
contact your ROTH representative.
About Synthetic Biologics, Inc.
Synthetic Biologics, Inc. (NYSE MKT: SYN) is a clinical-stage
biotechnology company developing pathogen-specific therapies for
serious infections and diseases, with a focus on protecting the
microbiome. The Company is developing an oral biologic to protect
the gut microbiome from intravenous (IV) antibiotics for the
prevention of C. difficile infection, an oral statin
treatment to reduce the impact of methane producing organisms on
constipation-predominant irritable bowel syndrome (C-IBS), and in
collaboration with Intrexon Corporation (NYSE: XON), a monoclonal
antibody combination for the treatment of Pertussis. In addition,
the Company is developing a Phase 2 oral estriol drug for the
treatment of relapsing-remitting multiple sclerosis (MS) and
cognitive dysfunction in MS. For more information, please visit
Synthetic Biologics' website at www.syntheticbiologics.com.
Logo -
http://photos.prnewswire.com/prnh/20130522/MM19465LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/synthetic-biologics-to-present-at-the-27th-annual-roth-conference-300044070.html
SOURCE Synthetic Biologics, Inc.